The Cancer Discovery editors proudly present this collection of impactful Immuno-oncology articles that have been published in the Journal.
-
β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
Ruiz de Galarreta M…Lujambio A Cancer Discovery September 2019. -
Immune Desertic Landscapes in Hepatocellular Carcinoma Shaped by β-Catenin Activation
Berraondo P…Melero I Cancer Discovery September 2019. -
Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming
Hundeyin M…Miller G Cancer Discovery September 2019. -
Unconventional T Cells in the Pancreatic Tumor Microenvironment: Thinking Outside the Box
Banerjee S…Saluja A Cancer Discovery September 2019. -
Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms
Cimen Bozkus C…Bhardwaj N Cancer Discovery September 2019. -
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
Parkhurst MR…Rosenberg SA Cancer Discovery August 2019. -
A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
Bentebibel SA…Diab A Cancer Discovery June 2019. -
Back to the Future: Rethinking and Retooling IL2 in the Immune Checkpoint Inhibitor Era
Sullivan RJ Cancer Discovery June 2019. -
Naïve T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers
Das RK…Barrett D Cancer Discovery April 2019. -
Wishing on a CAR: Understanding the Scope of Intrinsic T-cell Deficits in Patients with Cancer
Leick M and Maus MV Cancer Discovery April 2019. -
Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study
Daver N…Kantarjian H Cancer Discovery March 2019. -
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma
Kaloora S…Samuels Y Cancer Discovery November 2018. -
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Ribas A…Janssen RS Cancer Discovery October 2018. -
In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma
Frank MJ…Levy R Cancer Discovery October 2018.
Cancer Discovery Editorial Office
American Association for Cancer Research | Publishing Division
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (215) 446-7297 | E-mail: cancerdiscovery@aacr.org